Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

PAF antagonist evaluated in patients with rheumatoid arthritis; results disappointing

Sep. 22, 1998

Novel antiinflammatory azulenes disclosed by Kotobuki

Sep. 21, 1998

Selective and sensitive p38 MAP kinase inhibitor identified by SmithKline Beecham

Sep. 18, 1998

La Jolla identifies target of antibodies responsible for life-threatening autoimmune disorder

Sep. 17, 1998

Medical device for rheumatoid arthritis scheduled for October advisory panel review

Sep. 17, 1998

Advisory committee unanimously recommends approval for Enbrel

Sep. 17, 1998

Viragen acquires stake in Inflammatics; adds LeukoVAX to pipeline

Sep. 15, 1998

FDA approves, HMR begins shipping new treatment for adult rheumatoid arthritis

Sep. 14, 1998

Inhibitors of ICE activity described by Vertex

Sep. 14, 1998

Merck & Co. discovers another potent and selective COX-2 inhibitor

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...